Ophthalmology · Detroit, MI
NPI
1760420822
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4717 Saint Antoine St, Kresge Eye Institute
Detroit, MI, 48201
Phone (313) 577-8900
Groups this clinician bills Medicare through
Medicare paid, 2024
$109K
1,612 services
Medicare patients, 2024
394
Average age 75
Drug cost, 2024
$926K
6,136 prescriptions
Company payments, 2025
$21K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bret A Hughes was code 99214 (office e&m - established), 530 times for 333 patients. In total Bret A Hughes billed 1,612 services in 32 codes, and Medicare paid $109K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 530 | 333 | $83.67 | $44K |
| 92083 Vision, Hearing, and Speech Services | Office | 470 | 328 | $41.10 | $19K |
| 92133 Computerized Ophthalmic Imaging | Office | 224 | 219 | $22.71 | $5,087 |
| 99213 Office E&M - Established | Office | 138 | 111 | $54.98 | $7,587 |
| 76514 Ultrasound - Nonspecific | Office | 49 | 49 | $7.22 | $354 |
| 99212 Office E&M - Established | Office | 39 | 37 | $36.26 | $1,414 |
| 66984 Cataract Surgery | Facility | 29 | 25 | $321.24 | $9,316 |
| 92020 Ophthalmological E&M | Office | 26 | 26 | $18.46 | $480 |
| 76519 Ultrasound - Nonspecific | Office | 25 | 19 | $32.97 | $824 |
| 99204 Office E&M - New | Office | 20 | 20 | $94.48 | $1,890 |
| 66821 Cataract Surgery | Office | 16 | 15 | $219.06 | $3,505 |
By year: 2022 $129K for 1,444 services; 2023 $143K for 1,903 services; 2024 $109K for 1,612 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bret A Hughes prescribed most often to Medicare patients was Latanoprost, with 1,438 prescriptions and refills. In total Bret A Hughes wrote 6,136 Medicare prescriptions that cost $926K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,438 | 2,968 | 389 | $27K |
| Brimonidine Tartrate Generic | 832 | 1,608 | 201 | $39K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 672 | 1,437 | 187 | $19K |
| Timolol Maleate Generic | 450 | 943 | 119 | $16K |
| Dorzolamide Hcl Generic | 315 | 594 | 83 | $9,503 |
| Prednisolone Acetate Generic | 308 | 500 | 101 | $15K |
| Vyzulta Latanoprostene Bunod | 276 | 483 | 71 | $144K |
| Lumigan Bimatoprost | 256 | 488 | 77 | $118K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 248 | 392 | 62 | $130K |
| Simbrinza Brinzolamide/Brimonidine Tart | 220 | 380 | 58 | $74K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 147 | 290 | 51 | $39K |
| Combigan Brimonidine Tartrate/Timolol | 146 | 277 | 40 | $69K |
| Acetazolamide Er Acetazolamide | 111 | 195 | 33 | $6,442 |
| Pilocarpine Hcl Generic | 94 | 180 | 30 | $7,322 |
| Rhopressa Netarsudil Mesylate | 70 | 146 | 26 | $43K |
Brand drugs: 2,097 claims; generic drugs: 4,039 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bret A Hughes $21K ($21K in general payments such as food, travel and fees) from 9 companies. The largest payer was Bausch & Lomb Americas Inc. with $20K.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 21 | $20K |
| Abbvie Inc. ABBV | 9 | $272 |
| New World Medical,Inc. | 9 | $163 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $30.62 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $23.74 |
| Genentech USA, Inc. ROG.SW | 1 | $17.88 |
| Thea Pharma Inc. | 1 | $17.79 |
| Dompe US, Inc. | 1 | $17.57 |
| Surgical Specialties Corporation (us), Inc. (dba Corza Medical) | 1 | $6.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.